Announcements Trials

Browse Landscape

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Thoracic 2 Sarcoma 2 Plasma cell 1 Other solid neoplasm 1 Head & Neck 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Interventions

pembrolizumab 65 Nivolumab 58 Ipilimumab 32 Cyclophosphamide 22 Specimen Handling 16 Magnetic Resonance Spectroscopy 15 Biopsy 15 relatlimab 13 cemiplimab 13 fludarabine 12 Opdualag 12 binimetinib 10 Blood Specimen Collection 10 aldesleukin 9 Radiosurgery 9 encorafenib 8 Interleukin-2 8 atezolizumab 7 Immunotherapy 7 tebentafusp 6 mogamulizumab 6 fludarabine phosphate 6 Temozolomide 6 Surgical Procedures, Operative 6 Paclitaxel 6 Immunoglobulin G 6 CTLA-4 Antigen 6 Radiotherapy 5 Disulfides 5 Bevacizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Quality of Life × Dermatologic × Clear all

NCT02828202 2025-02-11

MelBase

Assistance Publique - Hôpitaux de Paris

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡